SEC Form 4 · accession 0001144204-15-048795
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert S Vaters
Officer — President & CFO · Director
Period of report
Aug 12, 2015
Accepted (ET)
Aug 13, 2015 · 11:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | Aug 12, 2015 | P | 12,385 | $1.3469 | A | 228,750 | D |
Table II — derivative securities
No Table II lines on this filing.